View Author
patient count group study therapy nvp therapy treatment baseline regimen netherland haart antiretroviral vaccination gastroenteriti switch antiretroviral therapy hospital level signi ficantly response result atv switch group cart group signi erasmus university rotterdam virological hepatitis plasma virological failure schedule trial failure 48 weeks effect change analysis adult t-cell nadir treatment-experienced patients interruption combination mutation ef ficacy treatment-naive patients ficantly lipodystrophy difference department <.0001 rotterdam hiv -2-infected patients resistance nevirapine hiv-infected patients health treatment interruption table virus atazanavir vaccine lipid center hospitalization disease university infection visit month follow-up medicine number zidovudine suppression erasmu population hiv-infected children tg levels unboosted atv
6 Most Recent Publications
|
Costs of gastroenteritis in the Netherlands, with special attention for severe cases
(Article)
Friesema, I.H.M. Lugnér, A.K. Bezemer, D.D.L. Smeulders, A. Fraaij, P.L.A. Bogerman, J. Heerbeek, H. van Pronk, M.J.H. Enk, J.G. van Uil, J.J. Andel, R.N.J. van Brinkman, K. Duynhoven, Y.T.H.P. van Duizer, E. Kortbeek, L.M. Notermans, D.W. Koopmans, M.P.G. Boer, R.F. de Kooistra-Smid, A.M.D. Norbruis, O.F. |
2011-12-01
|
|
A randomized controlled study of accelerated versus standard hepatitis B vaccination in HIV-positive patients
(Article)
Vries-Sluijs, T.E.M.S. de Hansen, B.E. Ende, M.E. van der Man, R.A. de Doornum, G.J.J. van Kauffmann, R.H. Leyten, E.M.S. Mudrikova, T. Brinkman, K. Hollander, J.G. den Kroon, F.P. Janssen, H.L.A. |
2011-04-01
|
|
Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir
(Article)
Vonderen, M.G.A. van Gras, L. Wit, F.W. Brinkman, K. Ende, M.E. van der Hoepelman, I.M. Wolf, F. de Reiss, P. |
2009-01-01
|
|
Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: The ATHENA cohort study
(Article)
Wit, F.W. Kesselring, A.M. Gras, L. Richter, C. Ende, M.E. van der Brinkman, K. Lange, J.M.A. Wolf, F. de Reiss, P. |
2008-03-15
|
|
Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-Week Treatment Interruption in Early Starters Netherlands study (TRIESTAN)
(Article)
Pogány, K. Vanvalkengoed, I.G. Brinkman, K. Prins, J.M. Nieuwkerk, P.T. Ende, I.D. Kauffmann, R.H. Kroon, F.P. Verbon, A. Nievaard, M.F. Lange, J.M.A. |
2007-04-01
|
|
Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients
(Article)
Prins, J.M. Brinkman, K. Keuter, M. Veenstra, J. Danner, S.A. Niesters, H.G.M. Osterhaus, A.D.M.E. Schutten, M. Ende, M.E. van der |
2003-01-01
|
